Ahead of World AIDS Day, Unitaid is announcing a US$22 million investment to accelerate the introduction and access to lenacapavir, a revolutionary long-acting HIV prevention option. Two injections of ...

Gilead (GILD) announced The New England Journal of Medicine, or NEJM, published the full results from the company’s pivotal ...

The UNAids ‘Take the Rights Path’ campaign calls for the removal of punitive laws and policies that marginalise key populations, including sex workers, men who have sex with men and people who inject ...

Global HIV rates drop 20 but challenges persist in ending AIDS by 2030 Explore breakthroughs like lenacapavir prevention ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But ...

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

Biannual vaccinations with the drug lenacapavir offers effective protection against HIV infection, according to phase-3 study ...

The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure ...

Discover the groundbreaking results of Lenacapavir, a twice-yearly injection that reduces HIV infection risk offering an ...

Lenacapavir, an injectable PrEP taken twice a year, demonstrated 96% efficacy in preventing HIV infections in a global Phase ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

If you’re polyamorous, you should imagine that all your partners are infected unless proven otherwise,” says Dr Agni Bose, a ...